Category: AstraZeneca’s immuno-oncology combo fails crucial Mystic trial in lung cancer

AstraZeneca’s immuno-oncology combo fails crucial Mystic trial in lung cancer

  1. AstraZeneca’s immuno-oncology combo fails crucial Mystic trial in lung cancer  FierceBiotech
  2. Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails  Xconomy
  3. AstraZeneca lung cancer failure sparks 16 percent share fall  Reuters
  4. AstraZeneca Shows the Peril of Going All-In  Bloomberg
  5. AstraZeneca shares plunge 16 percent on lung cancer failure  Times of India
  6. Full coverage

from Business – Google News http://www.fiercebiotech.com/node/487636

Advertisements